日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Female patients with vascular disease receive less medical optimization despite more health care utilization

尽管女性血管疾病患者的医疗资源利用率更高,但她们接受的医疗优化治疗却更少。

Lowenkamp, Mikayla N; Nassereldine, Hasan; Iams, Alexas; Tzeng, Edith; Reitz, Katherine M

Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials

胸部肿瘤研究者发起试验的开发、审查和启动

Gerber, David E; Wynters, Claire R; Prasad, Tanushree; Schnel, Ronny K; Zhang, Song; Stinchcombe, Thomas E; Villaruz, Liza C; Bauml, Joshua M; Iams, Wade T; Patil, Tejas; Liu, Stephen V; Horn, Leora; Hudak, John M; Camidge, D Ross

Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis

EGFR突变型非小细胞肺癌患者治疗方案及转移性疾病模式的变化:一项学术胸科医学研究者联盟注册研究分析

Stalker, Margaret; Grady, Connor B; Watts, Alex; Hwang, Wei-Ting; Chandrasekhara, Krishna; Sun, Fangdi; Liu, Geoffrey; Patel, Devalben; Nieva, Jorge; Herrmann, Amanda; Marrone, Kristen; Lam, Vincent K; Velcheti, Vamsidhar; Liu, Stephen V; Bravo Montenegro, Gabriela Liliana; Tompkins, William; Patil, Tejas; Weiss, Jared; Miller, Kelsey Leigh; Schwartzman, William; Dowell, Jonathan E; Shaverdashvili, Khvaramze; Villaruz, Liza; Cass, Amanda; Iams, Wade; Aisner, Dara; Aggarwal, Charu; Camidge, D Ross; Sun, Lova; Marmarelis, Melina E

Afatinib and Necitumumab in EGFR-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase Inhibitors

阿法替尼和奈西妥单抗治疗获得性酪氨酸激酶抑制剂耐药的EGFR突变型非小细胞肺癌

Myall, Nathaniel J; Whisenant, Jennifer G; Neal, Joel W; Iams, Wade T; Reckamp, Karen L; York, Sally; Berry, Lynne D; Shyr, Yu; Horn, Leora; Wakelee, Heather A; Padda, Sukhmani K

Brief Report: Relationship Between Tumor Volume and Clinical Outcomes in Relapsed SCLC

简报:复发性小细胞肺癌中肿瘤体积与临床结局的关系

Lu, Matthew; Byrd, Hayden; Chen, Heidi; Iams, Wade

Two Cases of Amivantamab-Induced Pneumonitis in Patients With NSCLC: Case Report

两例非小细胞肺癌患者因阿米万单抗诱发肺炎的病例报告

DeWeerd, Alexander J; Sun, Elizabeth; Iams, Wade T

Characteristics of Short-Term Survivors With ALK or ROS1-Altered Metastatic NSCLC

ALK或ROS1基因改变的转移性非小细胞肺癌短期生存者的特征

Liu, Kai-Lin; Watts, Alex; Grady, Connor B; Liu, Geoffrey; Patel, Devalben; Balaratnam, Karmugi; Liu, Stephen V; Montenegro, Gabriela Bravo; Nie, Yunan; Nieva, Jorge; Herrmann, Amanda; Marrone, Kristen; Lam, Vincent; Sun, Fangdi; Dowell, Jonathan; Schwartzman, William; Velcheti, Vamsidhar; Fankuchen, Olivia; Ullah, Tasfiq; Villaruz, Liza; Nguyen, Matthew; Weiss, Jared; Patel, Shetal; Miller, Kelsey; Iams, Wade; Chandrasekhara, Krishna; Tompkins, William; Patil, Tejas; Aisner, Dara; Camidge, D Ross; Hwang, Wei-Ting; Sun, Lova; Marmarelis, Melina E

Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors

达唑替纳联合帕博利珠单抗治疗接受低分割放射治疗的特定晚期实体瘤患者的 1b 期研究

Cooper, Benjamin T; Iams, Wade T; Page, David B; Yuan, Yuan; Gerber, Naamit K; Luke, Jason J; Gibbs, John P; Gregory, Richard C; Wong, Kwok-Kin; Deng, Jiehui; Perera, Samanthi A; Ding, Kai; Roberts, Emily R; Berger, Allison; Christensen, Camilla L; Tong, Erica Xin; Maldonado López, Angel E; Appleman, Vicky A; Leonard, E Jane; Parent, Alexander; Huang, Yu-Chung; Bay, Camden; Li, Cong; Lineberry, Neil; Raizer, Jeffrey; Olson, Daniel J; Chmura, Steven J

MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy

MOMENT登记研究:接受全身治疗的携带MET外显子14跳跃突变的晚期非小细胞肺癌患者

Thomas, Michael; Christopoulos, Petros; Iams, Wade T; Mazières, Julien; Cortot, Alexis B; Peled, Nir; Minuti, Gabriele; Smit, Egbert F; Audhuy, Francois; Berghoff, Karin; Eggleton, S Peter; Fries, Frank; Hildenbrand, Maike; Liu, Peter; Mahmoudpour, Seyed Hamidreza; Menzel, Christoph; Oksen, Dina

Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report

获得性 RUFY1-RET 重排作为 CD74-ROS1 重排非小细胞肺癌患者对劳拉替尼耐药的机制:病例报告

Wu, Jenny L; Iams, Wade T